mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
-0.02 |
0.8 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
0.053 |
0.8 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |